![]() Of the 503 dabigatran-treated patients in the entire study.Reported in ≥5% of patients were constipation (33/503, 7%) and nausea Trial, a total of 503 dabigatran-treated patients were administered idarucizumabĮither because they required an emergency surgery or urgent procedure, orīecause they presented with life-threatening or uncontrolled bleeding. ![]()
0 Comments
Leave a Reply. |